Clinical Trials Browser

Phase 1 × HER2-Positive Solid Tumors × Clear all

NCT04501770 2025-07-20

A Study of M802 (HER2 and CD3) in HER2-Positive Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

HER2-Positive Solid Tumors

NCT04280341 2023-08-25

JS001 in Combination With RC48-ADC in Treatment of HER2-Positive Advanced Malignant Solid Tumors

Phase 1 Unknown

Other solid neoplasm

HER2-Positive Solid Tumors

NCT04189211 2019-12-06

A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients

Phase 1 Unknown

Other solid neoplasm

HER2-Positive Solid Tumors